ArticleThe New England journal of medicine2020
Clinical Characteristics of Covid-19 in China.
Article in The New England journal of medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04573062 (Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health), which is not on this map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health
Who cites it
20 citing papers in PubMed.
- A Longitudinal Study of Immune Cells in Severe COVID-19 Patients.Frontiers in immunologyTrial
- Perovskite materials in X-ray detection and imaging: recent progress, challenges, and future prospects.RSC advances · 2024Review
- Epidemiological and clinical features of SARS-CoV-2 Omicron variant infection in Quanzhou, Fujian province: a retrospective study.Scientific reports · 2023Article
- Differences in clinical characteristics and liver injury between patients diagnosed with the Omicron subvariant BA.5.2 and the prototype of SARS-CoV-2: a single center retrospective study.BMC gastroenterology · 2023Article
- COVID-19 can lead to rapid progression of cervical intraepithelial neoplasia by dysregulating the immune system: A hypothesis.Journal of reproductive immunology · 2022Article
- Novel skewed usage of B-cell receptors in COVID-19 patients with various clinical presentations.Immunology letters · 2022Article
- A Review of COVID-19 in Relation to Metabolic Syndrome: Obesity, Hypertension, Diabetes, and Dyslipidemia.Cureus · 2022Review
- Factors Influencing Delayed Treatment in Patients With Breast Cancer During COVID-19 Pandemic.Frontiers in public health · 2022Article
- Changing trends of patient characteristics and treatment pathways during the COVID-19 pandemic: A cross-sectional analysis of 72,459 inpatient cases from the German Helios database.Frontiers in public health · 2022Article
- Article
- Observational
- Control of a multigroup COVID-19 model with immunity: treatment and test elimination.Nonlinear dynamics · 2021Article
- Social distancing merely stabilized COVID-19 in the United States.Stat (International Statistical Institute) · 2020Article
- SARS-CoV-2 and cancer: Are they really partners in crime?Cancer treatment reviews · 2020Review
- Comparison of clinical and microbiological diagnoses for older adults with COVID-19 in Wuhan: a retrospective study.Aging clinical and experimental research · 2020Article
- Caring for cancer patients in the Covid pandemic: choosing between the devil and deep sea.World journal of surgical oncology · 2020Review
- Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost.Biochemical pharmacology · 2020Review
- Perioperative preparation in thoracic day surgery: Battle against COVID-19.Thoracic cancer · 2020Article
- ACE2, Metformin, and COVID-19.iScience · 2020Review
- Review
Corrections and comments
- Commented on by
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
32220203What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.